ATE195182T1 - Überwachung von patienten mit lungenkrebs durch messung von nca 50/90 im blut - Google Patents

Überwachung von patienten mit lungenkrebs durch messung von nca 50/90 im blut

Info

Publication number
ATE195182T1
ATE195182T1 AT94106222T AT94106222T ATE195182T1 AT E195182 T1 ATE195182 T1 AT E195182T1 AT 94106222 T AT94106222 T AT 94106222T AT 94106222 T AT94106222 T AT 94106222T AT E195182 T1 ATE195182 T1 AT E195182T1
Authority
AT
Austria
Prior art keywords
nca
blood
lung cancer
measurement
patient
Prior art date
Application number
AT94106222T
Other languages
English (en)
Inventor
William Jeffrey Allard
Kwok K Yeung
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE195182T1 publication Critical patent/ATE195182T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT94106222T 1993-04-21 1994-04-21 Überwachung von patienten mit lungenkrebs durch messung von nca 50/90 im blut ATE195182T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5111193A 1993-04-21 1993-04-21
US19397694A 1994-02-08 1994-02-08

Publications (1)

Publication Number Publication Date
ATE195182T1 true ATE195182T1 (de) 2000-08-15

Family

ID=26729078

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94106222T ATE195182T1 (de) 1993-04-21 1994-04-21 Überwachung von patienten mit lungenkrebs durch messung von nca 50/90 im blut

Country Status (7)

Country Link
US (1) US5605804A (de)
EP (1) EP0621480B1 (de)
JP (1) JP3345697B2 (de)
AT (1) ATE195182T1 (de)
AU (1) AU681374B2 (de)
CA (1) CA2118759C (de)
DE (1) DE69425394T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2118760C (en) * 1993-04-21 2004-06-22 William Jeffrey Allard Diagnosis and monitoring of colon cancer patients by measurement of nca 50/90 in blood
EP0747705A1 (de) * 1995-06-09 1996-12-11 Bayer Corporation Spezifische Bestimmung von NCA 90 Glykoprotein im Blut eines Krebspatienten
US9944713B2 (en) 2004-11-24 2018-04-17 Medicinal Bioconvergence Research Center Antibody specific to the AIMP2-DX2
CN113748217B (zh) 2019-03-01 2023-08-25 仁慈生物分析公司 用于靶实体检测的系统、组合物和方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01120289A (ja) * 1987-11-05 1989-05-12 Suntory Ltd 非特異的交差抗原
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
CA2082605C (en) * 1991-12-30 2005-02-01 James J. Elting Monitoring of nca-bt in blood samples of breast cancer patients
CA2118760C (en) * 1993-04-21 2004-06-22 William Jeffrey Allard Diagnosis and monitoring of colon cancer patients by measurement of nca 50/90 in blood

Also Published As

Publication number Publication date
EP0621480A2 (de) 1994-10-26
DE69425394D1 (de) 2000-09-07
JPH06324045A (ja) 1994-11-25
DE69425394T2 (de) 2000-12-28
CA2118759A1 (en) 1994-10-22
JP3345697B2 (ja) 2002-11-18
CA2118759C (en) 2004-06-22
AU681374B2 (en) 1997-08-28
EP0621480B1 (de) 2000-08-02
AU5941994A (en) 1994-10-27
EP0621480A3 (de) 1995-09-06
US5605804A (en) 1997-02-25

Similar Documents

Publication Publication Date Title
Van den Besselaar et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system
NO163584C (no) Anordning for deteksjon av en bestanddel i en flytende proeve ved maaling av endringer i konduktivitet.
US5197017A (en) Potentiophotometric fibrinogen determination
FI941522A0 (fi) Menetelmä hemoglobiiniadditiotuotteiden määrittämiseksi
DE69230000D1 (de) Verfahren und testsatz zur messung von endogenen zytokinen
WO1995009559A3 (en) Detection of an acute myocardial infarction in a patient
RU94008063A (ru) Способ оценки состояния печени пациента
ATE194035T1 (de) Überwachung von patienten mit dickdarmkrebs durch messung von nca 50/90 im blut
DE69425394D1 (de) Überwachung von Patienten mit Lungenkrebs durch Messung von NCA 50/90 im Blut
SU1013853A1 (ru) Способ определени воспалительного процесса в организме
LaForce et al. Evaluation of the SonoClot Analyzer for the measurement of platelet function in whole blood
KR950703736A (ko) 치주염 발생의 사전 진단 방법 및 키트(methods and kits for evaluating risk of developing periodontitis)
Cheah et al. A rapid and simple blood sugar determination using the Ames reflectance meter and Dextrostix system: a preliminary report
EP0230343A3 (de) Verfahren zur Bestimmung von Glycerophosphaten in amniotischen Flüssigkeiten als diagnostischer Anzeiger
Roberts et al. Assay of thyroxine-binding globulin by polyacrylamide electrophoresis: normal values
Ibsen et al. Lipoprotein electrophoresis in recessive X-linked ichthyosis
SU1122294A1 (ru) Способ определени нарушени кровообращени в исследуемой сосудистой зоне
SU1655468A1 (ru) Способ диагностики стадий печеночной недостаточности
SU1666952A1 (ru) Способ контрол эффективности лечени юношеской артериальной гипертензии
Knapp et al. Comparison of an immunochemical assay for plasma fibrinogen and a turbidimetric thrombin clotting technique to discriminate hyperlipidaemic patients from healthy controls.
Kofstad 6.1. 3.3 Quality Specifications for pH and Blood Gases
ATE141335T1 (de) Verfahren zur bestimmung des cholesterins, zum nachweis von gefässkrankheiten und zur anhebung des anteils an hdl-cholesterin
DE3176408D1 (en) Method to check the validity of a breath sample for determining the blood-alcohol concentration
Lizana et al. Electronic timing of a high-speed immunonephelometric continuous-flow system
Andreasen Predictive value of decreasing antithrombin III in deep-vein thrombosis